Status:
COMPLETED
Symax International Study
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Vejle Hospital
Stryker Orthopaedics
Conditions:
Hip Osteoarthritis
Prosthesis Durability
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The uncemented Symax hip stem is developed through optimization of the uncemented Omnifit hip stem. The Symax stem design combines an anatomical anteverted proximal geometry with a straight distal sec...
Eligibility Criteria
Inclusion
- Patients requiring uncemented primary total hip arthroplasty (osteoarthritis, avascular necrosis and/or post-traumatic arthritis), age between 18-70 years, BMI less or equal to 35.
Exclusion
- Patients with bilateral hip complaints, impaired cognitive function and use of medication or illness influencing bone metabolism.
Key Trial Info
Start Date :
November 2 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03469687
Start Date
November 2 2004
End Date
October 11 2010
Last Update
March 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.